-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EM1leZkph8oUjMRBnePgrvRAtBbRnhBSfsc3yALEdRZXuWXBxswyPGL54GjJNu/5 KzMlrJnlHet0Wcl5rDt5jw== 0001209191-05-046061.txt : 20050906 0001209191-05-046061.hdr.sgml : 20050905 20050906174044 ACCESSION NUMBER: 0001209191-05-046061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050901 FILED AS OF DATE: 20050906 DATE AS OF CHANGE: 20050906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1204 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHITE JOHN P CENTRAL INDEX KEY: 0001238970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 051071237 MAIL ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD STE 110 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-09-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001238970 WHITE JOHN P C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 1 0 0 0 Common Stock 2005-09-01 4 M 0 1000 32.79 A 11075 D Common Stock 2005-09-01 4 S 0 1500 32.79 D 9575 D Stock Option (Right to Buy) 20.313 2005-09-01 4 M 0 1000 0.00 D 2001-03-15 2010-03-14 Common Stock 1000 6000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Michael G. Atieh by Power of Attorney 2005-09-06 -----END PRIVACY-ENHANCED MESSAGE-----